What is the likely diagnosis and recommended evaluation for a patient with RBC 3.11 ×10⁶/µL, hemoglobin 9.4 g/dL, hematocrit 31.3 %, mean corpuscular volume (MCV) 100.6 fL, mean corpuscular hemoglobin (MCH) 30.2 pg, and red cell distribution width (RDW) 17.4 %?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Macrocytic Anemia with Elevated RDW

This patient has macrocytic anemia (MCV 100.6 fL) with elevated RDW (17.4%), indicating a heterogeneous red cell population that most likely represents either vitamin B12/folate deficiency, dimorphic anemia (combined nutritional deficiencies), or early myelodysplastic syndrome—requiring immediate measurement of vitamin B12, folate, serum ferritin, and transferrin saturation.

Laboratory Pattern Analysis

The CBC reveals:

  • Anemia: Hemoglobin 9.4 g/dL (low)
  • Macrocytosis: MCV 100.6 fL (elevated, normal range ~80-97 fL)
  • Elevated RDW: 17.4% (significantly elevated, indicating anisocytosis)
  • Normal MCH: 30.2 pg (within normal range)

The combination of macrocytosis with markedly elevated RDW is critical—this is not a uniform macrocytic process.

Differential Diagnosis Priority

Most Likely: Nutritional Deficiency

The elevated RDW distinguishes this from pure vitamin B12/folate deficiency (which typically shows uniform macrocytosis with normal RDW initially). The elevated RDW suggests either:

  1. Dimorphic anemia (combined B12/folate AND iron deficiency)—the RDW has superior discriminatory ability for detecting mixed nutritional deficiencies 1
  2. Early or treated nutritional deficiency with mixed cell populations
  3. Vitamin B12 or folate deficiency alone with reticulocytosis

Alternative Considerations

  • Myelodysplastic syndrome: Particularly in older patients, macrocytosis with dysplastic features
  • Chronic kidney disease: Though CKD typically causes normocytic anemia 2, evaluate renal function
  • Hemolysis with reticulocytosis: Would elevate MCV and RDW
  • Alcohol use or liver disease: Common causes of macrocytosis
  • Medications: Methotrexate, hydroxyurea, antiretrovirals

Recommended Evaluation Algorithm

Immediate Laboratory Testing

Essential first-line tests 2:

  1. Vitamin B12 level (most critical)
  2. Serum folate
  3. Serum ferritin (assess iron stores)
  4. Transferrin saturation (TSAT)
  5. Reticulocyte count (assess bone marrow response)
  6. Peripheral blood smear (evaluate for:
    • Hypersegmented neutrophils (B12/folate deficiency)
    • Oval macrocytes vs. round macrocytes
    • Dysplastic features
    • Mixed cell populations)

Second-line Testing Based on Initial Results

  • If ferritin low (<25 ng/mL) or TSAT <20%: Confirms dimorphic anemia 1
  • If B12 <200 pg/mL: Add methylmalonic acid and homocysteine for confirmation
  • If abnormalities in multiple cell lines (WBC, platelets): Hematology referral for possible bone marrow evaluation 2
  • Renal function tests (BUN, creatinine): CKD evaluation 2
  • Thyroid function: Hypothyroidism causes macrocytosis
  • Liver function tests: Assess for chronic liver disease

Clinical History Focus

Specifically assess for:

  • Dietary intake: Vegetarian/vegan diet (B12), poor nutrition (folate)
  • Gastrointestinal symptoms: Malabsorption, diarrhea, previous gastric surgery
  • Medications: Metformin (B12 malabsorption), anticonvulsants, chemotherapy
  • Alcohol consumption: Major cause of macrocytosis
  • Bleeding history: Menstrual losses, GI bleeding (suggests iron deficiency component)
  • Neurological symptoms: Paresthesias, ataxia, cognitive changes (B12 deficiency)
  • Age and comorbidities: Older age increases MDS risk

Critical Clinical Pitfalls

Common Errors to Avoid

  1. Assuming pure macrocytic anemia: The elevated RDW (17.4%) indicates this is NOT a uniform process—do not treat empirically with only B12/folate without checking iron status 1

  2. Missing dimorphic anemia: In populations with high prevalence of nutritional deficiencies, combined iron and B12/folate deficiency is common and can present with microcytic, normocytic, OR macrocytic indices depending on which deficiency predominates 1

  3. Overlooking MDS in older patients: If age >60 years with unexplained macrocytosis and cytopenias, maintain high suspicion for myelodysplastic syndrome

  4. Ignoring the reticulocyte count: A low reticulocyte count with anemia indicates inadequate bone marrow response and narrows the differential significantly 2

  5. Treating without confirming diagnosis: Always obtain B12 and folate levels BEFORE starting replacement therapy, as treatment will obscure the diagnosis

Management Implications

  • If B12/folate deficiency confirmed: Initiate appropriate replacement therapy
  • If dimorphic anemia: Address BOTH iron and B12/folate deficiencies simultaneously
  • If iron deficiency in non-menstruating patient: Evaluate for GI bleeding with endoscopy 2
  • If unexplained or refractory: Hematology referral for bone marrow biopsy consideration

The elevated RDW is the key discriminating feature here—it signals heterogeneity that demands comprehensive nutritional assessment rather than assuming a single etiology 1.

Related Questions

Interpret the laboratory results (macrocytic anemia with low RBC, hemoglobin, hematocrit; high MCV and RDW; mild thrombocytopenia; lymphopenia; left‑shift; elevated anion gap; elevated BUN and creatinine with reduced eGFR; low albumin; high total protein and globulin; hypercalcemia; elevated alkaline phosphatase; mildly elevated CRP) and determine the most likely diagnosis and recommended next diagnostic and therapeutic steps.
What is the differential diagnosis and appropriate evaluation for a patient presenting with leukopenia, low hematocrit, elevated mean corpuscular volume (MCV), and decreased mean corpuscular hemoglobin concentration (MCHC)?
What is the significance of a hematocrit of 49.5 %, an MCV of 103.1 fL, and an MCHC of 29 g/dL, and how should this be evaluated and managed?
Interpret the complete blood count for a female patient with hemoglobin 11.9 g/dL, hematocrit 40 %, MCV 71 fL, MCH 21.2 pg, MCHC 29.8 g/dL, and RDW 20 %.
What does a normal hemoglobin and hematocrit with elevated mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH) indicate, and how should it be evaluated?
How well studied is the effect of red light exposure on sleep onset?
With negative hepatitis B core antibody (anti‑HBc), positive hepatitis B surface antibody (anti‑HBs), and negative hepatitis B surface antigen (HBsAg) on labs drawn on [date], what should be the next step in management?
What are alternatives to a 1‑hour oral glucose tolerance test using a glucose drink?
What is the appropriate dose of B‑complex vitamins for cyclic mastalgia in adults?
Explain beta‑blockers, including their mechanism of action, clinical uses, typical dosing, contraindications, and monitoring considerations.
Should Vermox (mebendazole) be repeated for treatment of Ascaris (round‑worm) infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.